Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers
Part of paid clinical trials in Arcadia, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT06524973
- Status
- Recruiting
Conditions
- Metastatic Pancreatic Adenocarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Telemedicine — OTHERAttend telehealth self-management coaching sessions
- Counseling — OTHERAttend telehealth self-management coaching sessions
- Best Practice — OTHERReceive standard of care
- Questionnaire Administration — OTHERAncillary studies
- Inrweview — OTHERAncillary studies
Study Details
This clinical trial evaluates the impact of telehealth self-management coaching sessions on quality of life in pancreatic cancer survivors and their family care givers (FCGs). Patients with pancreatic cancer experience many symptoms because of the disease and treatment, which can have a negative impact on quality of life. Patients and their families have unmet needs during treatment, including a lack of quality of life programs that offer support to patients. Supporting patients and families on managing the physical symptoms, emotional well-being, social well-being and spiritual well-being with telehealth self-management coaching sessions may help improve quality of life, manage symptoms from treatment, and support families in their role as caregivers during treatment.
Key Dates
- Start date
- Oct 7, 2024
- Status verified
- Nov 2025
- Primary completion
- May 3, 2027
- Completion
- May 3, 2027
Study Design
- Enrollment
- 136 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Arm A (telehealth self-management coaching sessions)Patients and FCGs attend telehealth self-management coaching sessions over 40-60 minutes every other week for 6 sessions over 3 months.
- Active Comparator: Arm B (standard of care)Patients and FCGs receive standard of care on study.
Primary Outcome Measure
Patient reported quality of life (QOL) [ Time Frame: At baseline and at 3 months post randomization ]
Central Contacts
- Vincent Chung, MD626-359-8111
Locations (22)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope at Arcadia | Arcadia | California | 91007 | |
| City of Hope Corona | Corona | California | 92879 | |
| City of Hope at Duarte | Duarte | California | 91010 | Vincent Chung, MD |
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | |
| City of Hope at Glendale | Glendale | California | 91204 | |
| City of Hope at Glendora | Glendora | California | 91741 | |
| City of Hope Seacliff | Huntington Beach | California | 92648 | |
| City of Hope at Irvine Lennar | Irvine | California | 92618 | |
| City of Hope at Irvine Sand Canyon | Irvine | California | 92618 | |
| City of Hope Antelope Valley | Lancaster | California | 93534 | |
| City of Hope at Long Beach Elm | Long Beach | California | 90813 | Vincent Chung, MD |
| City of Hope at Long Beach Worsham | Long Beach | California | 90808 | |
| City of Hope Mission Hills | Mission Hills | California | 91345 | |
| City of Hope at Newport Beach Fashion Island | Newport Beach | California | 92660 | |
| City of Hope at Palmdale | Palmdale | California | 93551 | |
| City of Hope - Santa Clarita | Santa Clarita | California | 91355 | |
| City of Hope at Simi Valley | Simi Valley | California | 93065 | |
| City of Hope South Pasadena | South Pasadena | California | 91030 | |
| City of Hope at Thousand Oaks | Thousand Oaks | California | 91361 | |
| City of Hope South Bay | Torrance | California | 90503 | |
| City of Hope Upland | Upland | California | 91786 | |
| City of Hope West Covina | West Covina | California | 91790 |
Find similar trials in Arcadia, CA
Related Studies
- Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic CancerPHASE3 · Recruiting · Eleison Pharmaceuticals LLC. · Whittier, California
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS MutationsPHASE3 · Recruiting · SWOG Cancer Research Network · Anchorage, Alaska
- TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic AdenocarcinomaPHASE1 · Recruiting · University of California, Davis · Sacramento, California
- Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye ConjugatePHASE2 · Enrolling By Invitation · Hoag Memorial Hospital Presbyterian · Newport Beach, California